DK1007717T3 - Metoder og sammensætninger til cancerterapi under anvendelse af gener, der koder for interferon-beta - Google Patents
Metoder og sammensætninger til cancerterapi under anvendelse af gener, der koder for interferon-betaInfo
- Publication number
- DK1007717T3 DK1007717T3 DK98944526T DK98944526T DK1007717T3 DK 1007717 T3 DK1007717 T3 DK 1007717T3 DK 98944526 T DK98944526 T DK 98944526T DK 98944526 T DK98944526 T DK 98944526T DK 1007717 T3 DK1007717 T3 DK 1007717T3
- Authority
- DK
- Denmark
- Prior art keywords
- methods
- interferon
- compositions
- cancer therapy
- coding genes
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 102000003996 Interferon-beta Human genes 0.000 title 1
- 108090000467 Interferon-beta Proteins 0.000 title 1
- 229960001388 interferon-beta Drugs 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 238000011275 oncology therapy Methods 0.000 title 1
- 102000014150 Interferons Human genes 0.000 abstract 2
- 108010050904 Interferons Proteins 0.000 abstract 2
- 238000011065 in-situ storage Methods 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 238000001727 in vivo Methods 0.000 abstract 1
- 229940079322 interferon Drugs 0.000 abstract 1
- 229940047124 interferons Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000012385 systemic delivery Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/565—IFN-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- Toxicology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5725497P | 1997-08-29 | 1997-08-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1007717T3 true DK1007717T3 (da) | 2006-05-29 |
Family
ID=22009467
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK98944526T DK1007717T3 (da) | 1997-08-29 | 1998-08-25 | Metoder og sammensætninger til cancerterapi under anvendelse af gener, der koder for interferon-beta |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP1007717B8 (https=) |
| JP (3) | JP4124565B2 (https=) |
| KR (1) | KR100699285B1 (https=) |
| CN (1) | CN100342019C (https=) |
| AT (1) | ATE316145T1 (https=) |
| AU (1) | AU740428B2 (https=) |
| BR (1) | BR9812138A (https=) |
| CA (1) | CA2300480C (https=) |
| CY (1) | CY1105029T1 (https=) |
| CZ (2) | CZ297314B6 (https=) |
| DE (1) | DE69833264T2 (https=) |
| DK (1) | DK1007717T3 (https=) |
| EA (1) | EA003256B1 (https=) |
| EE (1) | EE04873B1 (https=) |
| ES (1) | ES2257817T3 (https=) |
| HU (1) | HU224422B1 (https=) |
| IL (2) | IL134593A0 (https=) |
| IS (1) | IS2318B (https=) |
| NO (1) | NO20000990L (https=) |
| NZ (1) | NZ503401A (https=) |
| PT (1) | PT1007717E (https=) |
| SK (1) | SK286821B6 (https=) |
| TR (1) | TR200000532T2 (https=) |
| WO (1) | WO1999010516A2 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE357935T1 (de) | 2001-01-22 | 2007-04-15 | Biogen Idec Inc | Verfahren zum erhöhen der zuführung einer therapeutischen nukleinsäure |
| US8058248B2 (en) * | 2001-04-26 | 2011-11-15 | The United States Of America As Represented By The Secretary Of Agriculture | Foot and mouth disease virus vaccine comprising interferons |
| CN1388248A (zh) * | 2001-05-25 | 2003-01-01 | 钱其军 | 高效表达干扰素的肿瘤细胞内特异性增殖的腺病毒及其构建方法 |
| EP1835032A1 (en) * | 2006-03-14 | 2007-09-19 | Université de Liège | A self-inactivating recombinant lentiviral vector for the inhibition of HIV replication |
| MD36Z (ro) * | 2008-12-02 | 2010-01-31 | Василе ЖОВМИР | Metodă de tratament diferenţiat al carcinomului ductal in situ neinvaziv al glandei mamare |
| MD35Z (ro) * | 2008-12-02 | 2010-01-31 | Василе ЖОВМИР | Metodă de apreciere a riscului dezvoltării carcinomului neinvaziv in situ al glandei mamare |
| MD23Z (ro) * | 2008-12-02 | 2010-01-31 | Василе ЖОВМИР | Metodă de tratament diferenţiat al carcinomului lobular in situ neinvaziv al glandei mamare |
| MD24Z (ro) * | 2008-12-02 | 2010-01-31 | Василе ЖОВМИР | Metodă de tratament diferenţiat al carcinomului neinvaziv al glandei mamare |
| CN103505722B (zh) * | 2012-06-19 | 2016-04-13 | 苏州丁孚靶点生物技术有限公司 | 干扰素在治疗/预防对常规抗肿瘤疗法有抗性的肿瘤中的用途及相关的产品和方法 |
| US20190125804A1 (en) * | 2016-06-15 | 2019-05-02 | Tissue Regeneration Therapeutics Inc. | Anti-cancer use of genetically modified human umbilical cord perivascular cells (hucpvc) |
| JP7644722B2 (ja) * | 2019-06-01 | 2025-03-12 | シベック バイオテクノロジーズ，インコーポレイティド | 真核細胞への遺伝子編集システムの送達のための細菌プラットフォーム |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2122519C (en) * | 1994-04-29 | 2001-02-20 | Rudolf Edgar Dr. Falk | Cancer treatment and metastasis prevention |
| EP1369487A3 (en) * | 1994-08-16 | 2004-04-07 | Crucell Holland B.V. | Recombinant vectors derived from adenovirus for use in gene therapy |
| US5952221A (en) * | 1996-03-06 | 1999-09-14 | Avigen, Inc. | Adeno-associated virus vectors comprising a first and second nucleic acid sequence |
-
1998
- 1998-08-25 AT AT98944526T patent/ATE316145T1/de active
- 1998-08-25 CZ CZ20000733A patent/CZ297314B6/cs not_active IP Right Cessation
- 1998-08-25 CN CNB988094878A patent/CN100342019C/zh not_active Expired - Fee Related
- 1998-08-25 IL IL13459398A patent/IL134593A0/xx active IP Right Grant
- 1998-08-25 DE DE69833264T patent/DE69833264T2/de not_active Expired - Lifetime
- 1998-08-25 CZ CZ20060489A patent/CZ299095B6/cs not_active IP Right Cessation
- 1998-08-25 EE EEP200000102A patent/EE04873B1/xx not_active IP Right Cessation
- 1998-08-25 DK DK98944526T patent/DK1007717T3/da active
- 1998-08-25 WO PCT/US1998/017606 patent/WO1999010516A2/en not_active Ceased
- 1998-08-25 TR TR2000/00532T patent/TR200000532T2/xx unknown
- 1998-08-25 AU AU92051/98A patent/AU740428B2/en not_active Ceased
- 1998-08-25 SK SK248-2000A patent/SK286821B6/sk not_active IP Right Cessation
- 1998-08-25 EA EA200000270A patent/EA003256B1/ru not_active IP Right Cessation
- 1998-08-25 BR BR9812138-3A patent/BR9812138A/pt not_active Application Discontinuation
- 1998-08-25 KR KR1020007002157A patent/KR100699285B1/ko not_active Expired - Fee Related
- 1998-08-25 JP JP2000507824A patent/JP4124565B2/ja not_active Expired - Fee Related
- 1998-08-25 ES ES98944526T patent/ES2257817T3/es not_active Expired - Lifetime
- 1998-08-25 NZ NZ503401A patent/NZ503401A/xx not_active IP Right Cessation
- 1998-08-25 PT PT98944526T patent/PT1007717E/pt unknown
- 1998-08-25 HU HU0002913A patent/HU224422B1/hu not_active IP Right Cessation
- 1998-08-25 CA CA002300480A patent/CA2300480C/en not_active Expired - Fee Related
- 1998-08-25 EP EP98944526A patent/EP1007717B8/en not_active Expired - Lifetime
-
2000
- 2000-02-11 IS IS5374A patent/IS2318B/is unknown
- 2000-02-17 IL IL134593A patent/IL134593A/en not_active IP Right Cessation
- 2000-02-28 NO NO20000990A patent/NO20000990L/no not_active Application Discontinuation
-
2003
- 2003-12-10 JP JP2003412621A patent/JP3953458B2/ja not_active Expired - Fee Related
-
2005
- 2005-03-23 JP JP2005085060A patent/JP4219335B2/ja not_active Expired - Fee Related
-
2006
- 2006-04-17 CY CY20061100525T patent/CY1105029T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2149774T3 (es) | Aportacion dirigida de genes que codifican proteinas secretoras. | |
| FI962154A0 (fi) | Koostumus terapeuttisten tuotteiden in vivo valmistusta varten | |
| DK0559884T3 (da) | Rekombinante virusvektorer til ekspression i muskelceller | |
| EE200700058A (et) | Glkoslitud interferoon-beeta, selle kasutamineja seda sisaldav farmatseutiline kompositsioon, meetod interferoon-beeta-1a aktiivsuse pikendamiseks ja leiutisekohase valgu valmistamiseks | |
| DK1007717T3 (da) | Metoder og sammensætninger til cancerterapi under anvendelse af gener, der koder for interferon-beta | |
| DK1093383T3 (da) | Lægemiddelafgivelsessystem omfattende et homeobox-peptid og et cytotoksisk eller antineoplastisk lægemiddel | |
| UA66417C2 (en) | Recombinant adenovirus affecting canines, pharmaceutical composition | |
| NZ505063A (en) | Pharmaceutical use of long pentraxin PTX3 in treating tumour conditions | |
| DK1144600T3 (da) | Akt-3-nukleinsyre, polypeptider og anvendelser deraf | |
| DK0889969T3 (da) | Rekombinante adenovirale til genterapi af humane tumorer | |
| ATE371031T1 (de) | Herpes-simplex virus, das das gen von interleukin-12 exprimiert, und dessen verwendung zur behandlung von krebs | |
| TR199901190T2 (xx) | Interferon-(alfa) N�kleik asitlerinin verilmesi ve sentezlenmesi i�in y�ntemler ve bile�imler. | |
| DE69903559D1 (de) | Verwendung von neuen zelltod inducierenden mitteln im synergismus mit interferon | |
| ATE247978T1 (de) | Verwendung von ompa enterobakterproteinen um zielgerichtet antigen-präsentierende zellen anzusteuern | |
| DK0676413T3 (da) | Inteferon-alfa/beta-bindingsprotein, dets fremstilling og anvendelse | |
| NZ516777A (en) | Method for delivery of therapeutic agents, particularly nucleic acids, using a solution of dextrin |